marijuana stocks news

Cara Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016

Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, November 3, 2016, at 4:30 p.m. ET to report third quarter 2016 financial results and provide a corporate update.

To participate in the conference call, please dial 855-445-2816 (domestic) or 484-756-4300 (international) and refer to conference ID 90388150. A live webcast of the call can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com.

An archived webcast recording will be available on the Cara website beginning approximately two hours after the call.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Vapotherm, Inc. (VAPO) Releases Next Generation of Capital Unit: Precision Flow Hi-VNI™ System

Vapotherm® Releases Next Generation of Capital Unit: Precision Flow Hi-VNI™ System Vapotherm,…

Cara Therapeutics, Inc. (CARA) to Announce First Quarter 2024 Financial Results on May 13, 2024

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13,…

4Front Ventures Corp. (FFNTF) to Open Its Third Dispensary in Massachusetts

4Front Ventures Corp. to Open Its Third Dispensary in Massachusetts 4Front Ventures…